Journal Report

RHEUMATOLOGY AND THERAPY

Download PDF
Journal Information
Journal Title
RHEUMATOLOGY AND THERAPY
Publisher
SPRINGER
ISSN
2198-6576
E-ISSN
2198-6584
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓
2020 ✓
2019 ✓
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Effectiveness of Upadacitinib Versus Other Advanced Therapies in Rheumatoid Arthritis After Tumor Necrosis Factor Inhibitor Use in the United States
Christina Charles-Schoeman, Kurt Oelke, Christopher D. Saffore et al.
2026-11-3
DOI: 10.1007/s40744-026-00885-8
Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis: 2-Year Data from Germany, Austria, and Switzerland in the Observational UPHOLD Study
Eugen Feist, Sara Bär, Maren Sieburg et al.
2026-11-3
DOI: 10.1007/s40744-026-00888-5
Interleukin-6 Blockade in Refractory Neuro-Behçet’s Disease: A Systematic Literature Review
Ayaka Maeda, Yuki Iizuka, Kaoru Takase-Minegishi et al.
2026-10-26
DOI: 10.1007/s40744-026-00886-7
Patient-Reported Disease Activity, Health-Related Quality of Life, and Coping in Systemic Lupus Erythematosus: A Cross-Sectional Online Survey in Switzerland (Lupus-IMPACT)
Marten Trendelenburg, Jasmin Annabelle Schulz, Kristin Schmiedeberg et al.
2026-10-25
DOI: 10.1007/s40744-026-00887-6
Bimekizumab in Chinese Patients with Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results from the Phase 3 BE MOBILE 1 Study
Jieruo Gu, Liangjing Lu, Qiang Wang et al.
2026-10-23
DOI: 10.1007/s40744-026-00875-w
Impact of the Sociodemographic Index on Efficacy/Safety of Tofacitinib in Patients with Rheumatoid Arthritis: Post Hoc Analysis of Phase 2/3/3b/4 Studies
Grace Wright, Eduardo Mysler, Kevin D. Roberts et al.
2026-10-16
DOI: 10.1007/s40744-026-00881-y
Effectiveness of Newly Initiated Tofacitinib and Biologic DMARDs in Patients with Rheumatoid Arthritis
Katherine P. Liao, Chandrasekar Gopalakrishnan, Jinoos Yazdany et al.
2026-10-15
DOI: 10.1007/s40744-026-00882-x
Long-Term Safety and Efficacy of Upadacitinib in Patients with Psoriatic Arthritis: 5-Year Results from the Phase 3 SELECT-PsA 1 Study
Iain B. McInnes, Koji Kato, Marina Magrey et al.
2026-10-7
DOI: 10.1007/s40744-026-00884-9
Sociodemographic and Clinical Determinants of Colchicine Adherence in Adults with Familial Mediterranean Fever: A Cross-Sectional Study
Ertugrul Cagri Bolek, Emre Bilgin, Riza Can Kardas et al.
2026-9-25 Vol. 13 Issue 5 Pages 1357-1377
DOI: 10.1007/s40744-026-00883-w
Updates on the Evaluation of Lupus Arthritis
Wei Tang, Alberto Nordmann-Gomes, Leila Khalili et al.
2026-9-4 Vol. 13 Issue 5 Pages 1223-1240
DOI: 10.1007/s40744-026-00879-6
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 6, 2026 16:13